98360-32-8

Basic information

• Product Name: 2(1H)-Quinolinone, 3,4-dihydro-6-[4-[1-(3-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-, trans-
• CAS NO: 98360-32-8
• Molecular Formula: C20H27N5O3
• Molecular Weight: 385.466
• Mol File: 98360-32-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2(1H)-Quinolinone, 3,4-dihydro-6-[4-[1-(3-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-, trans-(CAS DataBase Reference)
• NIST Chemistry Reference: 2(1H)-Quinolinone, 3,4-dihydro-6-[4-[1-(3-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-, trans-(98360-32-8)
• EPA Substance Registry System: 2(1H)-Quinolinone, 3,4-dihydro-6-[4-[1-(3-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-, trans-(98360-32-8)

Safety Data

• Hazardous Substances Data: 98360-32-8(Hazardous Substances Data)

Upstream product

• 98454-51-4 1-((1R,3S)-3-Benzyloxy-cyclohexyl)-5-(4-chloro-butyl)-1H-tetrazole 
• 54197-66-9 3,4-dihydro-6-hydroxy-2(1H)-quinolinone 
• 87153-00-2 6-{4-[1-((1R,3S)-3-Benzyloxy-cyclohexyl)-1H-tetrazol-5-yl]-butoxy}-3,4-dihydro-1H-quinolin-2-one 
• 73963-72-1 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril 
• 98454-51-4 1-((1R,3R)-3-Benzyloxy-cyclohexyl)-5-(4-chloro-butyl)-1H-tetrazole 
• 87153-00-2 6-{4-[1-((1R,3R)-3-Benzyloxy-cyclohexyl)-1H-tetrazol-5-yl]-butoxy}-3,4-dihydro-1H-quinolin-2-one 

Relevant articles and documents

Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. IV. Synthesis and biological activity of the metabolites of 6-[4-(1-cyclohexyl-1H-5-tetrazolyl)butoxy]-2-oxo-1,2,3,4- tetrahydroquinoline (OPC-13013)

-